Dr. Bratman is Scientist at Princess Margaret Cancer Centre Research Institute and Assistant Professor of Radiation Oncology & Medical Biophysics at the University of Toronto. He received his MD and PhD from Columbia University in 2009 followed by postdoctoral research and clinical training at Stanford Cancer Institute. Since joining The Princess Margaret in 2014, Dr. Bratman has served as Staff Radiation Oncologist within the Wharton Head and Neck Centre and has led basic, translational, and clinical research studies on head and neck cancer and circulating biomarkers.
Dr. Bratman's primary research focus is on improving outcomes for patients with head and neck cancer and other cancers through optimized detection and personalized treatments. His laboratory is currently developing and validating blood-based biomarkers for detecting and monitoring the presence of cancer.
Sci Rep. 2017 Dec 01;7(1):16723
Int J Radiat Oncol Biol Phys. 2017 Dec 01;99(5):1307
(bratman s[Author] OR bratman sv[Author]) AND ("2006/01/01"[PDAT] : "3000/12/31"[PDAT]); +24 new citations
These pubmed results were generated on 2017/09/14
Otolaryngol Head Neck Surg. 2017 Aug 01;:194599817726756
Radiother Oncol. 2017 Aug;124(2):225-231
Eat Weight Disord. 2017 Jul 24;:
Radiother Oncol. 2017 Jul 20;:
Clinical Utility of Epstein-Barr Virus DNA Testing in the Treatment of Nasopharyngeal Carcinoma Patients.
Int J Radiat Oncol Biol Phys. 2017 Aug 01;98(5):996-1001
Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
Cancer. 2017 Jun 13;:
Scientist, Princess Margaret Cancer Centre
Assistant Professor, Department of Medical Biophysics, University of Toronto
Assistant Professor, Department of Radiation Oncology, University of Toronto